Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema

By Gang Cheng   Lindsell Christopher J.   Moellman Joseph   Sublett Wesley   Hart Kim   Collins Sean   Bernstein Jonathan A.  

Allergy and Asthma Proceedings, Vol. 34, Iss. 3, 2013-05 ,pp. : 267-273

OceanSide Publications, Inc

Access to resources Recommend Favorite

The long-acting beta-agonist controversy: A clinical dilemma

By Lang David M.   Davis Ray S.  

Allergy and Asthma Proceedings, Vol. 28, Iss. 2, 2007-03 ,pp. : 136-144

OceanSide Publications, Inc

Access to resources Recommend Favorite

The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma

By Mansfield Lyndon E.  

Allergy and Asthma Proceedings, Vol. 29, Iss. 2, 2008-03 ,pp. : 103-108

OceanSide Publications, Inc

Access to resources Recommend Favorite

Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia

By  

Early Intervention In Psychiatry (Electronic), Vol. 10, Iss. 5, 2016-10 ,pp. : 365-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema

By  

Current Molecular Medicine, Vol. 10, Iss. 4, 2010-06 ,pp. : 354-360

Bentham Science Publishers

Access to resources Recommend Favorite